Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.

The aim of this study was to evaluate the experience of a cohort of patients utilizing the etonogestrel implant (Implanon) in an Irish General Practice setting. This study involved a survey administered as a telephone questionnaire, to a cohort of women (n=75) who opted to use the etonogestrel implant. 53% reported problems with the implant post insertion, the commonest problem being irregular bleeding in 22% cases. Early removals were documented in 28% cases, of which, 29%, were caused by irregular bleeding. Based on this study, it is evident that women have high expectations of the implant, and counselling about what they can expect during use is important in order to avoid unreasonable expectations. This study also demonstrates that the use of the etonogestrel implant is a valuable contraceptive option, which can be successfully delivered in a GP setting, for both patients of the practice as well as patients referred by colleagues locally.